MedPath

Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia

Not Applicable
Recruiting
Conditions
Parkinson Disease
Essential Tremor
Temporomandibular Joint Disorders
Dysphonia
Dystonia
Drug Induced Dystonia
Dyskinesias
Tic Disorders
Ulnar Nerve Entrapment
Torticollis
Registration Number
NCT05317390
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Brief Summary

This research involves retrospective and prospective studies for clinical validation of a DystoniaNet deep learning platform for the diagnosis of isolated dystonia.

Detailed Description

Isolated dystonia is a movement disorder of unknown pathophysiology, which causes involuntary muscle contractions leading to abnormal, typically patterned, twisting movements and postures. A significant challenge in the clinical management of dystonia is due to the absence of a biomarker and associated 'gold' standard diagnostic test. Currently, the diagnosis of dystonia is guided by clinical evaluations of its symptoms, which lead to a low agreement between clinicians and a high rate of diagnostic inaccuracies. It is estimated that only 5% of patients receive an accurate diagnosis at symptom onset, and the average diagnostic delay extends up to 10.1 years. This study will conduct retrospective and prospective studies to clinically validate the performance of DystoniaNet, a biomarker-based deep learning platform for the diagnosis of isolated dystonia.

The retrospective studies will clinically validate the diagnostic performance of the DystoniaNet algorithm (1) in patients compared to healthy subjects (normative test), and (2) between patients with dystonia and other neurological and non-neurological conditions (differential test).

The prospective randomized study will validate the performance of DystoniaNet algorithm for accurate, objective, and fast diagnosis of dystonia in the actual clinical setting.

This research is expected to advance the DystoniaNet algorithm for dystonia diagnosis into its clinical use for increased accuracy of dystonia diagnosis. Early detection and diagnosis of dystonia will enable its early therapy and improved prognosis, having an overall positive impact on healthcare and patients' quality of life.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Correctness of clinical diagnosis of dystonia using the DystoniaNet algorithm4 years

Correctness of dystonia diagnosis (yes dystonia/no dystonia) will be established using the DystoniaNet machine-learning algorithm

Time of clinical diagnosis of dystonia using the DystoniaNet algorithm4 years

The length of time (in months) from symptom onset to clinical diagnosis will be established using the DystoniaNet machine-learning algorithm

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Massachusetts Eye and Ear Infirmary

🇺🇸

Boston, Massachusetts, United States

Massachusetts Eye and Ear Infirmary
🇺🇸Boston, Massachusetts, United States
Kristina Simonyan, MD, PhD
Contact
617-573-6016
simonyan_lab@meei.harvard.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.